Home> Announcements> International topics> Trilateral Cooperation (JPO-EPO-USPTO)> Trilateral Project 24.1-Biotechnology> Trilateral Project 24.1-Biotechnology 075
Main content starts here.
Such claims reciting means plus function would be considered not commensurate in scope with the disclosure which enables only a single means. However, such claims are authorized by 35 U.S.C. Sec. 112, 6th paragraph, if the claim is drawn to a combination of elements.